Article
Leading refractive experts discuss the possible events that lead tomicro and macro striae and how they handle them
Sling Therapeutics announces topline efficacy and safety data from Phase 2b/3 LIDS trial on linsitinib
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Glaukos announces several positive clinical updates for its iDose platform
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
Greek researchers report rare case of fungal endophthalmitis